From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Clinical data
ATC code
  • none
CAS Number
  • 1797132-54-7 ☑Y
PubChem CID
  • 118796428
  • 29341725 ☑Y
Chemical and physical data
Formula C20H27NO3
Molar mass 329.44 g·mol−1
3D model (JSmol)
  • Interactive image

25G-NBOMe (NBOMe-2C-G) is a derivative of the phenethylamine hallucinogen 2C-G, which acts as a highly potent partial agonist for the human 5-HT2A receptor.[1]



The Riksdag added 25G-NBOMe to Narcotic Drugs Punishments Act under swedish schedule I ("substances, plant materials and fungi which normally do not have medical use") as of January 16, 2015, published by Medical Products Agency (MPA) in regulation LVFS 2014:11 listed as 25G-NBOMe, and 2-(2,5-dimetoxi-3,4-dimetylfenyl)-N-(2-metoxibensyl)etanamin.[2]

United Kingdom

This substance is a Class A drug in the United Kingdom as a result of the N-benzylphenethylamine catch-all clause in the Misuse of Drugs Act 1971.[3]

See also


  1. ^ https://bitnest.netfirms.com/external.php?id=%257DbxUaPRU%2505%255CG%252B%2527%252AFQ%2502%2518%2508U%250ATv
  2. ^ https://lakemedelsverket.se/upload/lvfs/LVFS_2014_11.pdf
  3. ^ "The Misuse of Drugs Act 1971 (Ketamine etc.) (Amendment) Order 2014". www.legislation.gov.uk.
Retrieved from "https://en.wikipedia.org/w/index.php?title=25G-NBOMe&oldid=805631090"
This content was retrieved from Wikipedia : http://en.wikipedia.org/wiki/25G-NBOMe
This page is based on the copyrighted Wikipedia article "25G-NBOMe"; it is used under the Creative Commons Attribution-ShareAlike 3.0 Unported License (CC-BY-SA). You may redistribute it, verbatim or modified, providing that you comply with the terms of the CC-BY-SA